Clinical Trial Update: Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whey protein isolate (Immunocal) for effects on core behavioral areas in children with autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Immunocal (Whey protein isolate)

Snippet

Sponsor: Nova Southeastern University | Conditions: Autism Spectrum Disorders | Phase 2 | Status: COMPLETED